Pure Global
NCT05904639

Decoding Your Diet (DYD)

Multivariable Transcriptomic Analysis, Dietary Patterns and Cardiovascular Risk in African Americans
Morehouse School of Medicine·Phase 1·ClinicalTrials.gov·geneticNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cardiovascular Disease
Drug/Device/Intervention
Decoding Your Diet
Study type
Interventional
Intervention type
genetic
Sponsor & location
Primary sponsor
Morehouse School of Medicine
Location
Atlanta, United States of America
Timeline & enrollment
Phase
Phase 1
Start date
Jul 01, 2023
End date
Jul 01, 2024
Enrollment
15 participants
Primary outcome

Differential changes in gene expression from baseline to end of study.

Summary

Our study will determine if a high quality AHA plant-based diet intervention can promote a
 genetic signature that is protective against CVD. Our development of GE mutational signatures
 in Blacks/African Americans with a high CVD burden can inform of changes patients can
 implement in their diet and lifestyle to decrease the CVD risk burden.

ICD-10 classifications
Cardiovascular disease, unspecifiedHypertensive heart diseaseHeart disease, unspecifiedAtherosclerotic cardiovascular disease, so describedAtherosclerotic heart disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05904639
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05904639 through Pure Global AI's free database. This Phase 1 trial is sponsored by Morehouse School of Medicine and is currently Not yet recruiting. The study focuses on Cardiovascular Disease. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.